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Tumors of  the  plasma cell  series  often produce  large  amounts  of proteins 
which  may be found in  serum in  the  form of  7S  T-globulin,  19S  T-gloublin, 
/3~,-globulin,  or  Bence  Jones  protein,  and  in  the  urine  primarily  as  Bence 
Jones  protein.  Although  instances  of  heterogeneous  myeloma proteins  have 
been described, both in man (1-3) and in transplantable plasma cell tumors in 
mice (4-7), these proteins are usually extremely homogeneous when compared 
with their normal counterparts which are highly heterogeneous in a number of 
physicochemical  properties.  They  lend  themselves  to  isolation  in  relatively 
large amounts and high degree of purity,  thus  being well suited for physico- 
chemical and serological studies. Although these proteins fall into four distinct 
classes, they are related in structure as evidenced by serological cross-reactions, 
and all cross-react with normal 7S "},-globulin  (1,  8-13).  In addition,  each ap- 
pears  to  have  a  counterpart  in  normal  serum where  the  7S  "y-, 19S  "},-, and 
/3~A-classes of immunoglobulins  are now clearly recognized.  Current  evidence 
indicates that they represent three classes of antibodies  (14,  15). 
In recent years, a number of genetically determined factors have been described  in 
human 7S T-globulin.  Of the seven factors dearly defined,  Gin(a)  (16),  Gin(b) (17), 
Gin(x)  (18), and Gin(r) (19) are determined by genes at one locus. In whites,  factors 
Gin(a)  and  Gm(b)  are produced  by genes  which  behave as  alternate  alleles  (17), 
whereas both factors in Negroes appear to be produced by a single allele called Gm  ab 
(20). Two alternate alleles at another locus determine the factors Inv(a) and Inv(b) 
(21-22).  The Gm and Inv loci are independent in population studies  (21, 23);  the 
frequencies  of  the  different Inv types make linkage  studies  difficult,  and  a  slight 
linkage between the two loci has so far not been excluded. The seventh factor, Gin-like 
(24), occurs in Negroes and is rare in most other ethnic groups (25). So far, only one 
Gm-like(+)  individual  has  been found  in  whites  among  thousands  of  individuals 
tested (26). The relationship between the Gm locus and the locus of Gin-like has not 
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been delineated due to the fact that aU Negroes are Gm(a +b +) (20, 25); the Gm-like 
locus is also independent of the Inv locus in population studies (25). 
The primary purpose of the present study was to attempt to delineate these 
genetic  characters  in  the  products  of  plasma  cell  tumors  particularly  with 
the objective of discerning alterations,  possibly related  to the malignant pro- 
cess, in a  comparison with the individual's normal ")'-globulin. In view of the 
close relationship  of  19S 5"-globulins,  ~2A-globulins and  Bence Jones  proteins 
to the major group of 7S 5,-globulins,  these proteins  were also studied for the 
presence of the different factors. The normal genetic factors were observed in 
representatives of all types of myeloma proteins.  Certain unusual distributions 
of genetic factors were observed but these were explainable by the concept that 
these  proteins  represented  extreme  elevations  of  individual  moieties  in  the 
spectrum  of -l-globulins  rather  than  that  the  proteins  were  truly  abnormal 
because  of  the  malignant  process. 
TABLE I 
Test System for the Can(a) Factor Showing Inhibition by Can(a+)  Normal  T-Globulin 
Reagents: Anti-Gin(a)  Smejsa diluted 1:35. 
Group O Rho red cells coated with anti-Rho •.  J. 
7S T-globulin  concentration  Gra(a-F)  Gin(a--) 
mg/ml 
2.0 
1.0 
0.50 
0.25 
0.12 
0.06 
0.03 
0.015 
0.008 
Controls: Anti-Gm(a)  +  saline +  coated cells:  3 
Anti-Gm(a)  +  saline +  uncoated cells: 0 
Coated cells +  saline:  0 
7S T-globulins +  saline +  coated cells: 0 
Materials and Methods 
Sera were obtained from patients with a clinical diagnosis of multiple myeloma or Walden- 
strt~m's macroglobulinemia. In a few instances,  sera were obtained  from patients  with  in- 
conclusive or no evidence of multiple myeloma when a sharp "monoclonal" peak appeared on 
agar electrophoresis. When purified, these  proteins  gave similar results  as the proteins  of 
typical multiple myeloma patients. They are, therefore, not discussed as a separate group. 
Purification Procedures.--Myeloma proteins  were  purified by  zone  electrophoresis  on 
starch as previously described (27). One serum (Piz. in Fig. 1) was separated, using pevikon 
as supporting medium (27 a). The proteins were eluted from half-inch segments, and the seg- M. IIARBOE, C. K. OSTERLAND, M. MANNIK, H. G. KUNKEL  721 
ment corresponding to the center of the myeloma peak used for typing. In some instances, 
the proteins eluted from a  series  of segments were brought to the same concentration and 
tested for inhibiting capacity in the specific test systems described later. All 7S T-myeloma 
proteins referred to gave a  sharp monoclonal peak on agar electrophoresis. 19S "y-globulins 
were purified from sera  of patients  with WaldenstrSm's macroglobulinemia by procedures 
adapted  in each case to the physicochemical properties of the macroglobulin. Bence Jones 
proteins were  obtained by (Nt~),SO4 precipitation  or  concentrating urine which had  been 
extensively dialyzed against running tap water. Zone electrophoresis on starch was used as the 
final purification step in many instances. The macroglobulin and Bence Jones protein prepara- 
tions were tested for purity by analytical ultracentrifugation in a Spinco model E ultracentri- 
fuge, immunoelectrophoresis (28), and double diffusion  tests in agar (12). 
Classification of Mydoma Protdns.--The myeloma proteins were classified as 7S ~/-globullns 
or ~lu-giobulins by immunological techniques using antisera  which had  been  adsorbed  so 
Factor 
Gm(a) 
Gm(b) 
Gm(x) 
Gm-like 
Inv(a) 
Inv(b) 
Reagents 
Aggintinator 
Smejsa 
A. Berg 
Tenoux 
Carp 
Travuikova 
Lucas 
TABLE II 
or Determination of Gm and Inv Types 
Anti-D 
J.J. 
N. Berg 
26 R 
Warren 
Roehm 
Ham 
No. of 
dilutions 
tested of 
myeloma 
protein* 
* Starting at a  concentration of 1 mg/ml of purified protein. 
:~ Number of doubling dilutions 
Inhibiting capacity~ 
Positive 7S  Negative 7S 
v-globulin  "y-globulin 
>5  0 
5  0 
>5  0 
4  0 
>--4  0 
>4  0 
which inhibit the agglutination,  starting at  1 mg/ml. 
they reacted specifically with each kind of protein. The 7S "y-myeloma  proteins and  Bence 
Jones proteins were classified in groups I and II according to criteria to be described elsewhere 
(29). The classification of myeloma proteins corresponds directly to Korngold's grouping (10). 
Bence Jones protein group I  corresponds to group B, and group II to group A in Korngold's 
classification (11). 
Genetic Typing.--Tests for Gm(a), Gm(b), and Gm(x) factors were made by a  slide tech- 
nique (30). The test system for determination of the  Gm(a) factor is illustrated in Table L 
Common to all reactions were group O, Rh-positive red cells coated with anti-Rho J.J., and 
a  constant,  optimal, dilution of anti-Gm(a)  Smejsa.  It is seen that  Gm(a-)  normal 7S "y- 
globulin separated by zone electrophoresis on starch was not able to inhibit the agglutination 
at a concentration of 2 mg/ml, whereas similarly purified Gm(a+)  7S "y-globulin inhibited the 
agglutination completely in seven successive doubling dilutions. Purified  myeloma  proteins 
were tested in five doubling dilutions starting at a protein concentration of 1 mg/ml. In order 
to regard the myeloma protein as Gm(a+) it was required that all these five dilutions inhibit 
the agglutination completely, whereas the presence of strong agglutination in all five dilutions 
made us regard  the myeloma protein  as  Gm(a--).  Only these two reaction patterns  were 
observed. The test systems for the other factors are shown in Table II. Tests for Gm-like, 
Inv(a), and Inv(b) were made with a tube technique (26). All agglutinators were from non- 
rheumatoid sera.  The reactions were read with a blind technique, and the results were easily 
reproducible. The term "inhibiting capacity (units)" used in the figures refers to the number 722  GENETIC CHARACTERS O~' ttUMAN "y-GLOBIYLINS 
of doubling  dilutions which  completely inhibited the agglutination, starting at a  protein 
concentration  of  1 mg/ml.  Protein determinations were  performed  by a  modified  Folin- 
Ciocalteu method, using Cohn Fr II 5,-globulin as standard. 
RESULTS 
Gm Characters in 7S "y-Myeloma Proteins.--Since the inheritance of the Gm(a) 
and  Gin(b)  types is different in whites and  Negroes,  the findings on isolated 
TABLE III 
Gm and Inv Types of Isolated 7S y-Mydoma Proteins  from American Whites 
Gm(a+b-) 
Gm(a+b+) 
Gin(a-b+) 
Gin(a-b-) 
Number tested ............ 
15 
0 
2 
30 
47 
Inv(a-4-b-) 
Inv(a+b~-) 
Inv(a-b~-) 
Inv(a-b-) 
3 
0 
19 
6 
28 
6 
~5 
E 
v  4 
6 
Serum  Piz.  :  Protein  curve 
Inhibition  of  anti-Gin(b) 
x  by fractions  of serum  Piz. 
•  by fractions  of a  normal 
6m {a-b+)  serum 
Inhibiting 
capacity 
{units) 
I0 
9 
8 
7 
6 
5 
4 
3 
2 
-  I 
0 
¢3 
a-  li 
0 ¸  J  "  I  l~  i  J  I  i  I  i  i  I  i  i  i 
?_  4 /  6  8  I0  12  14  16  18  20  22  24  26 
Segment  number 
Fro. 1. Zone electrophoresis of serum Piz. showing that the myeloma protein is Gm(b+) 
and 16 times more inhibiting than normal Gin(a-b+) 5'-globulin of similar electrophoretic 
mobility. The proteins of each segment were brought to the same concentration before testing. 
In all figures, "inhibiting capacity (units)" refers to the number of doubling dilutions which 
completely inhibited the agglutination of the respective test systems, starting at a concentra- 
tion of 1 mg/ml. 
myeloma  proteins  will  be  described separately for  these  two  ethnic  groups. 
The  Gin(a)  and  Gin(b)  types of forty-seven isolated 7S ~/-myeloma proteins 
obtained  from  whites  are  included  in  Table  III.  Fifteen  of  them  were 
Gm(a+b--)  and  two  Gm(a--b+),  whereas  none  possessed both  characters. ~[.  HARBOE,  C.  K.  OSTERLAND,  M.  MANNIK,  H.  G.  KUNKEL  723 
These frequencies  are strikingly different from those in normal sera  of white 
Americans where 91 per cent are Gin(b+) and 43 per cent Gm(a+bW) (20). 
The  inhibiting  capacity  of  isolated  myeloma proteins  was  subsequently 
compared with that of similarly isolated 7S ~,-globulin from normal individuals 
of the same  Gm types. Of seven  Gm(a+b-)  myeloma proteins,  three gave 
identical inhibition and  four inhibited in  one  more  doubling  dilution than 
Gm(a+b-)  normal "r-globulin-tested  in  equivalent concentrations.  In con- 
trast,  two Gm(a--b+)  myeloma proteins  had a  definitely greater inhibiting 
capacity than Gm(a-b+) normal 3,-globulin. One of them inhibited in four 
and the other in three additional doubling  dilutions  when directly compared 
with normal T-globulins  of the same  Gm type and identical  electrophoretic 
mobility. One of these comparisons is illustrated in Fig.  1. 
TABLE IV 
Gm Types of Whole Serum  and Isolated 7S T-Myeloma  Protein from Forty American  Whites 
Gm types of whole serum 
Gm types of isolated 
7S 3'-myeloma  proteins 
a-I-b-  a-kb-~  a-b+  a-h- 
a+b-  2  11  0  0 
a+b+  0  0  0  0 
a--b+  0  1  1  0 
a-b-  3  3  14  5 
The  Gm types of the myeloma protein and the normal T-globulin  of the 
same sera were compared using three different approaches: first, by comparing 
the inhibiting capacity of whole serum with that of the isolated myeloma pro- 
tein. The results are given in Table IV. In thirty cases, a number of dilutions 
of whole serum inhibited the agglutination in the Gin(b)  test system, whereas 
the isolated  myeloma protein typed as Gm(bW)  in only two of these  cases. 
Such findings indicate that the normal ~,-globulin often is Gm(bW)  when the 
myeloma protein is  Gm(b-). Or,  to express it in a  different  way: typing of 
whole serum indicated that thirty sera were Gin(b+), whereas this character 
was present in the myeloma protein in only two (about 7 per cent) of these 
individuals.  Similar experiments with regard to the Gm(a) factor gave different 
results  to the effect that the Gm(a) type of the myeloma protein was identical 
with that of the normal 3'-globulin in thirteen (65 per cent)  of twenty cases. 
In the remaining  seven  cases, the myeloma protein was  Gm(a--)  when the 
normal T-globulin appeared to be Gm(aW). In five cases, both myeloma protein 
and whole serum typed as Gin(a--b-), indicating that the amount of normal 
T-globulin was too low to show up in the test systems. This interpretation was 
borne  out by the findings in agar- and immunoelectrophoresis.  The finding of 
whole myeloma sera being Gin(a--b--) has been reported previously (30 a). 724  GENETIC  CHARACTERS  OF  HIYMAN  ~-GLOBU'L1NS 
The second approach is illustrated in Fig. 2, which shows the protein curve 
after zone electrophoresis of myeloma serum Mar.  The proteins eluted from 
each of 24 segments were brought to the same concentration and tested for 
inhibiting  capacity  in  the  Gm(a)  and  Gm(b)  test  systems.  The  antigenic 
character as determined by agar diffusion is indicated by the lines in the upper 
portion of the chart. No inhibition of anti-Gm(a)  was  observed by segments 
20 
t5 
Io 
0 
~  4 
8  3 
2  1 
Serum  Mor. 
~  :  Protein curve 
o  Inhibition of anti-Gin(a) 
x  Inhibition  of anti-Gm(b) 
o  o  4 
o  3 
:  ]_,_ 
Segment number 
FIG.  2.  Zone electrophoresis of  serum Mar., showing that  the  myeloma protein  is 
Gin(a--b-), whereas the normal "/-globulin  ahead of the peak is Gm(a+b-). The antigenic 
character of the proteins of each segment was determined by agar diffusion  tests using specific 
anfisera as indicated by the lines in the upper portion of the figure. 
4, 5, and 6, which corresponded to the myeloma protein. Segments just ahead 
of the peak (8 to 12) which contained normal "),-globulin did however inhibit 
anti-Gm(a).  Segments 13  through 24 did not inhibit and did not contain 7S 
"y-globulin as judged from double diffusion tests in agar. None of the segments, 
nor the whole serum, inhibited anti-Gin(b). In this case, therefore, the normal 
~/-globulin  was  Gm(a+b--)  and  the  myeloma  protein  Gm(a-b-).  This 
technique was used in fifteen cases.  In all instances it gave the same results 
as the interpretation after typing of whole serum and isolated myeloma pro- 
tein. None of the cases investigated indicated that the Gm(a) character could 
be present in the myeloma protein when it was absent in the normal 3'-glob- 
ulin. ~. HARBOE~ C. K. OSTERLAND, M. MANNIK, H. G. KUNKEL  725 
The third approach was  used in  serum Wei.,  where the  myeloma protein 
was a  7S "y-globulin  which precipitated in the cold (cryoglobulin). The serum 
was diluted 1:5 with distilled water. About 95 per cent of the myeloma protein 
was  removed by subsequent precipitation in  the cold. Mter washing,  it was 
dissolved in saline and typed as Gin(a-b-).  The supernatant, which contained 
the other serum proteins and a trace of myeloma protein, was dialyzed against 
saline and concentrated to the original serum volume. It typed as Gm(a-Fb-}-) 
Serum  Ni. 
:  Protein  curve 
0  Inhibition  of  anti-Gm(a) 
x  Inhibition  of anti-Gm(b) 
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FIc. 3. Zone electrophoresis  of serum Ni., showing that the myeloma  protein is Gin(a+), 
as is the normal T-globulin  on both sides of the peak. 
thus directly demonstrating that a myeloma protein may be Gin(a- b- ) when 
the normal "},-globulin in the same serum is Gm(a+b-}-). 
The possible  effects of  contaminating  normal  "y-globulin  in  the  myeloma 
protein preparations were considered carefully. It is clear that when the peak 
types as Gm-negative, it may safely be regarded as Gm-negative. When there 
is inhibition, this may be due to the protein itself or to contaminating normal 
"},-globulin. Figs. 3 and 4 illustrate the experimental approach to this problem. 
Fig. 3 shows the zone electrophoresis of serum Ni. which typed as Gm(a+b-) 
in whole serum. When the proteins from individual segments of the block were 
tested, it was found that the normal 7-globulin on both sides of the peak in- 
hibited  anti-Gm(a), and  so did  the myeloma protein to a  somewhat greater 726  GENETIC  CHARACTERS  OF HUMAN  ~-GLOBLrLINS 
extent. The comparison was made, referring to equivalent protein concentra- 
tions, and showed that the myeloma protein itself was Gm(a-4-).  Fig. 4 shows 
the findings on serum Ha. which is from a  Negro.  The whole serum typed as 
Gm(a+b-k). Again, the normal "r-globulin on both sides of the peak inhibited 
in the Gin(a) test system, and the inhibition was about the same in the peak. 
In contrast, the normal v-globulin inhibited in the Gm(b) test system, whereas 
there was a  definite decrease in inhibiting capacity in the  peak.  In this case 
Serum  Ha. 
Protein  curve 
o  Inhibition of onti-Gm(a) 
x  Inhibition  of  anti-Gin(b) 
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Fro. 4. Zone electrophoresis  of serum Ha., showing that the myeloma protein and the 
normal 3'-globulin on both sides of the peak are Gm(a+). The normal 3"-globulin also is 
Gm(b+), whereas the myeloma  protein is Gin(b--) as shown by the fall in inhibiting capadty 
in the segments directly under the peak. 
the myeloma protein was regarded as Gm(a+b-).  The slight inhibition in the 
Gin(b) test system by the segment which would be used as routine for typing 
(segment 4)  could be  accounted for by the  contaminating normal  Gm(b+) 
"y-globulin. 
Thirty-six myeloma proteins of 7S 3,-globulin type were tested for the Gin(x) 
character.  Fig.  5  illustrates  one  which  was  Gm(a+x-4-);  eleven  were 
Gm(a+x--), and twenty-four Gm(a--x--). In nine cases of Gin(a+) myeloma 
proteins, both the peaks  and  the whole sera  could be tested for the  Gm(x) 
character.  Only one serum was  Gm(x+),  the peak also being  of  this  type. 
The Gm(x) character was not observed in the whole serum when it was absent 
in the isolated myeloma protein. ~£. HARBOE,  C. K. OSTERLAND,  M. MANNIK, H. G. KUNE.EL  727 
Seven sera were obtained from Negroes with 7S 5,-myeloma proteins.  Six of 
them were Gm(a+b+) in whole serum, and one Gin(a--b+). The latter type 
is  not characteristic of Negroes  and is probably due to admixture of white 
genes (20). This serum was therefore discarded from the material The myeloma 
proteins isolated  from the remaining six sera were of type Gm(a+b--). The 
routine myeloma protein preparation was clearly Gm(a+b-) in three cases. 
The zone electrophoresis of one of these sera is shown in Fig. 6, which demon- 
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FIG. 5. Zone electrophoresis  of serum Tan., showing that the myeloma protein and the 
normal ~'-globulin  ahead of the peak both are Gm(a+x+b-). 
strates that there was inhibition of both anti-Gin(a) and anti-Gm(b) in the 
region ahead of the peak corresponding to the normal "),-globulin, whereas the 
protein in the peak inhibited anti-Gm(a)  only. Three sera  showed patterns 
similar to that of Fig. 4. There was some inhibition in the Gm(b)  test system 
by  the  routine  myeloma protein  preparation.  Inhibition experiments  on  a 
number of segments showed, however, that this inhibition could be accounted 
for by the contaminating normal Gm(b+) "),-globulin. All six Negro myeloma 
proteins were Gm-like (-). It is noted that the present test system for Gm- 
like  (Carp/Warren)  is unaffected by the Gm(b)  type of the material to be 
tested.  It  could,  therefore,  be  used  to  demonstrate  the  Gm-like  factor in 
Gm(a+b--)  Negro  myeloma proteins.  The  original  test  system  (Bomb./ 728  GENETIC  CHARACTERS 0]~  HUMAN  ~t-GLOBULINS 
Warren) would not be used since only Gm(b-[-) sera can be typed for Gm-like 
with these reagents. 
Gra and Inv Factors in the Same Myeloma Protein and in Separate Fragments 
Produced by Papain Splitting.--Table III includes the Inv types of 28 isolated 
7S 3'-myeloma proteins. Three of them were Inv(a-Fb-) and 19 Inv(a-b-F). 
Six possessed none of the factors and no preparation was positive for both fact- 
ors. Inv factors were present both in group I  and in group II 7S T-myeloma 
proteins. 
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FIG. 6. Zone electrophoresis of serum from a Negro myeloma patient (Ben.). The normal 
')'-globulin ahead of the peak is Gin(a-l-b-I-), whereas the myeloma protein is Gin(a-l-b-). 
In marked contrast to the presence of only one Gm or Inv factor in a single 
myeloma protein, when factors a and b are concerned, was the observation that 
many myeloma proteins  were  Gin(a-I-)  and  at  the  same  time Inv(b-b).  In 
fact, the frequency distribution of the different Inv types was virtually identical 
in  Gm(a-I-)  and  Gm(a-)  myeloma proteins. 
Three 7S "y-myeloma proteins of type Gm(a-I-) and Inv(b-]-) were split by 
papain at pH 7.4 and the fragments separated by zone electrophoresis on starch 
as previously described (31). In all cases, the Gin(a) determining site was found 
on the F fragment only, whereas the Inv(b) determining site was only found 
on the S fragment. These findings were identical with those made by similar 
splitting of Fr II "y-globulin made from pools of normal sera or electrophoreti- 
cally isolated "),-globulin from individual normal sera. The Gm(a), Gm(x), and M.  HARBOE~ C.  K.  OSTERI,AND,  M.  MANNIK,  H.  G.  KUNKEL  729 
Gm(b)  factors were located on  the  F  fragment and  the  Inv(a)  and  Inv(b) 
factors  only on  S. 
Genetic  Characters  in ~,-Mydoma  Proteins.--Table  V  shows the  Gm and 
Inv types of fifteen isolated/3,~,-myeloma proteins.  All of them were dearly 
Gin(a-b-),  a  finding confirming previous findings by M~rtensson (32),  and 
Fahey and Lawler (33),  indicating that Gm characters are not present in/3~A- 
globulins. However, in striking contrast, Inv(a)  and Inv(b)  characters  were 
found in individual fl~-myeloma proteins. The frequency distribution of the 
different Inv types was similar in ~A- and 7S 7-myeloma proteins. Extensive 
experiments  were  made  to  rule  out  the  possibility  that  contaminating  7S 
v-globulin was responsible for the results. The fact that all preparations were 
Gm(a-b--)  in itself made this interpretation improbable, and all other tests 
TABLE V 
Con and Inv Types of Isolated t32a-Mydoma Proteins 
Gm(a+b-) 
Gm(a-[-b+) 
Gm(a-b-[-) 
Gm(a-b-) 
Number tested ............ 
0 
0 
0 
15 
15 
Inv(a-bb-) 
Inv(a+b-b) 
Inv(a-b+) 
Inv(a-b-) 
15 
showed that the contamination of 7S v-globulin in the preparations was very 
small and could not account for the type results. Determination of inhibiting 
capacity of proteins eluted in the "},- and fl-regions of starch blocks (of. Fig. 2) 
showed that  the serum v-globulin might possess  the  Inv(b)  factor when it 
was absent in the peak; in other instances it was present in both regions. 
The f~-myeloma proteins often show signs of heterogeneity, both in man 
(1)  and in transplantable plasma cell tumors in mice (5).  Serum Lew. showed 
two sharp peaks with slightly different electrophoretic mobility in agar elec- 
trophoresis.  Fig.  7 shows that a  partial separation of the two peaks was ob- 
tained by zone electrophoresis on starch. All segments of the block lacked in- 
hibiting capacity in the Gm(a), Gm(b), and Inv(b) test systems. The lack of 
inhibition in both  Gm test systems apparently was due to the very low 7S 
"r-globulin concentration in  this  serum.  This  was  borne  out  by very weak 
precipiting lines between the protein of segments 5 to 10 and rabbit anti-human 
7S T-globulin. The Inv(a)  test system showed a  clear difference between the 
two peaks: three segments from the first peak (segments 8 to 10) inhibited the 
agglutination  completely down  to  a  protein  concentration  of  0.12  mg/ml, 
segment 11 gave an intermediate pattern, and the segments corresponding to 
the second peak did not inhibit at a concentration of 1 mg/ml. It was concluded 
that the first peak was Inv(a-[-) and the second Inv(a--). This phenomenon of 730  GENETIC  CHARACTERS  OF  ttlJ'MAN  'y-GLOBD'LINS 
genetic heterogeneity does  not  appear  to be  a  general  one.  Two other/~- 
myeloma  sera  showing  electrophoretic heterogeneity had  constant  activity 
throughout the peak regions in the Inv(a) and Inv(b) test systems. 
Genetic Ckaracters in 19S 3,-Globulins and  Urinary  Bence Jones Proteins.- 
Six macroglobulins purified from sera of patients with Waldenstr0m's macro- 
globulinemia  were  Gin(a--b-),  again  confirming  M~rtensson's  (32),  and 
Fahey and Lawler's  (33)  findings  that  19S  "r-globulins lack  Gm characters. 
However, two of them were clearly Inv(b+). 
:  :Protein curve 
o  Inhibition of anti-lnv(a) 
I'anti- Inv (b) 
Serum Lew.  x  Inhibitionof~enti-Gm(o) 
Lanti-Gm (b) 
......  ~  Anti- 7S 2" 
A_  6  ~,~  Anti-/5'2A 
E  ~.5 
/  /  // 
E 
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e-  l  \  (opacity 
o3  j  \  /  ~  (units, 
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Fzo. 7. Zone electrophoresis  of a ~2A-myeloma  serum (Lew.), showing  two bands. Only the 
first of these (segments 8 to 10) is positive in the Inv(a) test system. The second peak (seg- 
ments 12 to 14) is Inv(a--). 
Eleven urinary  Bence Jones  proteins  were  tested.  All  were  Gm(a-b--), 
whereas six of them possessed an Inv character. Table VI  gives the data on 
Inv types of the isolated Bence Jones proteins as compared with those of the 
myeloma protein in the serum of the same patients. There was a striking cor- 
relation between the antigenic classification of Bence Jones proteins in groups 
I  and II  (29)  on the one hand and the Inv types on the other. Four Bence 
Jones proteins were of group II, all being Inv(a--b--),  whereas all but one of 
seven group I  Bence Jones proteins had an Inv character. 
Serum Spi. contained a myeloma protein of group II which was Inv(a--b+). M.  HAEBOE, C.  K.  OSTERLAND, M.  MANNIK, H.  G.  KUNKEL  731 
The Inv character was, nevertheless, not expressed in the urinary Bence Jones 
protein which was also of group II. 
Serum Ro. contained a myeloma protein of group I which was Inv(a--b--). 
The Bence Jones protein was clearly Inv(a+b--), thus showing that a certain 
genetic character may be present in the Bence Jones protein even though it is 
lacking in the same patient's myeloma protein. The patient was genetically of 
type Inv(a+b+)  since  both  these characters  could be demonstrated  in  the 
normal  7-globulin  which,  by zone  electrophoresis  of serum,  could  be easily 
separated from the myeloma protein (Fig.  2 in reference 34). 
TABLE VI 
In~  Types and Serological Classification of 7S "y-Mydoma Protein and  Urinary  Bence Jones 
Protein from Eleven Patients 
Myeloma protein  Bence Jones protein 
Patient 
Inv type  Group  Inv type  Group 
Ger. 
Car. 
DeM. 
Pat. 
Cure. 
Pro. 
Haw. 
Spi. 
Ro. 
Tan. 
Sel. 
Inv(a--b+) 
Not available 
Not available 
Inv(a-b+) 
No peak 
No peak 
Inv(a--b+) 
Inv(a--b+) 
Inv(a--b--) 
Inv(a--b+) 
Inv(a--b+) 
I 
II 
I 
I 
I 
Inv(a--b+) 
Inv(a--b--) 
Inv(a--b+) 
Inv(a--b--) 
Inv(a-b+) 
Inv(a--b--) 
Inv(a--b+) 
Inv(a--b--) 
Inv(a+b--) 
Inv(a--b+) 
Inv(a--b--) 
I 
II 
I 
II 
I 
II 
I 
II 
I 
I 
I 
DISCUSSION 
The present studies on genetic characters  in isolated myeloma proteins of 
various kinds have furnished considerable information concerning  these charac- 
ters in the corresponding proteins in normal sera, whereas no evidence indicated 
that the myeloma proteins are truly abnormal because of the malignant process. 
These investigations, presented in part previously (31, 34),  confirmed  the ob- 
servations on myeloma proteins of M~trtensson  (32),  and  Fahey and  Lawler 
(33) that Gin-determining sites are present only on 7S 7-globulins,  and showed 
that  Inv-determining  sites  are  present  in  addition  on  19S  *t-globulins,  /32A- 
globulins,  and Bence Jones proteins.  Certain  similar  findings  were  made  by 
Franklin et al.  (35). 
Mter papain splitting of pooled human "},-globulin, "}'-globulin from individual 
normal sera,  and 7S 7-myeloma proteins (31),  the Gm-determining sites were 
found only on the F fragment (36) and tbe Inv-determining sites only on the 732  GENETIC  CHARACTERS  OF  ~N  ~-GLOBULINS 
S fragment. The results with three highly homogeneous myeloma proteins are 
particularly  relevant  since  they  strongly  suggest  that  the  same  "y-globulin 
molecule contains the two sites in different fragments. Information on splitting 
of 7S T-globulin  molecules into so called heavy (H) and light (L) polypeptide 
chains by reduction and alkylation (37) along with the antigenic relationships 
between the H and L chains  and  the fragments produced by papain splitting 
(37 a) plus the occurrence  of L  chains  in Bence Jones proteins  (38), indicate 
that the Gm-determining site is present on the H chain and the Inv site on one 
of the L chains.  They are therefore on different polypepfide chains  within the 
7S T-globulin  molecule.  Previous data (31, 34) further indicate that there is a 
common  genetic  make-up  of  a  part  of  7S  ~,-globulin,  19S  T-globulin,  and 
/~2A-globulin. This is particularly interesting since this part of the 7S ")'-globulin 
molecule is known to contain the antibody combining site (39-41).  The findings 
are in agreement with previous findings which indicate that the immunological 
cross-reaction  between 7S ~,-globulin and the other proteins is due to antigenic 
determinants  present on the S fragment after splitting with papain,  whereas 
antigenic determinants present on the F fragment of 7S "pglobulin  appear not 
to be shared by the other proteins (41-44). 
Current  evidence indicates  that  7S "y-globulins, 19S */-globulins,  and  fl2A- 
globulins are produced by plasma cells or related cells in the normal individual, 
and  genetic  characters  are  demonstrable  on  all  these  proteins.  In  multiple 
myeloma, malignant cells of the plasma cell series produce the same kinds of 
proteins,  and  it  is  evident  that  the genetic  factor  Gm(a),  Gm(b),  Gm(x), 
Inv(a),  and Inv(b) may be expressed  in the tumor product.  Genetic  hetero- 
geneity was demonstrable in the protein product of the tumor in two  cases. 
In serum Lew., two sharp peaks were observed on agar electrophoresis.  Both 
peaks consisted of markedly increased amounts of fl2A-globulin and gave reac- 
tions  of identity  with  various  rabbit  antisera  to  human  7S ~'-g]obulin  and 
fl~A-globulin. Fig. 7 shows that the two peaks had different Inv types, one being 
Inv(a+)  and the other Inv(a--).  In case Ro., the myeloma protein in serum 
was a 7S "r-type protein of type Gm(a-b-),  Inv(a-b-),  whereas the urinary 
Bence Jones protein was Gm(a-b-),  Inv(a+b--). These findings may indi- 
cate that in case Lew. two different clones of cells produce the two/32A-globulins 
in serum,  and in case Ro. that one clone of plasma cells produce the myeloma 
protein and another clone the urinary Bence Jones protein. Somewhat similar 
findings were made by Potter and Kuff (6) who observed that a transplantable 
plasma cell neoplasm in inbred mice produced two different kinds of proteins, 
one of ~/-and the other of r-type immunologically.  Two stable lines could be 
established by serial  transplantation  from a  single  host,  one line  producing 
"r-type  and the other/~-type protein,  thus indicating  the proliferation of two 
different clones of cells in the original host. 
In heterozygous individuals it appears that  no myeloma protein or Bence M'.  HARBOE,  C.  K.  OSTERLAND,  M.  MANNIK,  H.  O.  KUNK.EL  733 
Jones protein contains both factors determined by alternate alleles at a single 
locus.  In patients  whose normal y-globulin was  Gm(a+b+),  the  myeloma 
protein was found to be of type Gm(a+b-),  Gin(a--b+),  or Gm(a-b-), 
whereas both factors never appeared together in the myeloma protein. Similar 
findings were made by M~rtensson (32) who observed that three out of twenty- 
four 7S 7-myeloma proteins were  Gm(b+)  and all three lacked the  Gin(a) 
character. Fahey and Lawler (33) indicated that some myeloma proteins were 
Gm(a+b+). However, when their figures are evaluated at equivalent protein 
concentrations, it  appears  that  the findings may well be  explained by con- 
taminating normal Gm(b+) ~,-globulin  in the myeloma protein preparations. 
Since the frequency of the Gm(b) factor is so low in isolated myeloma proteins, 
the lack of Gm(a+b+) myeloma proteins might be fortuitous, although this 
appears improbable when adding up M~rtensson's (32) and the present data. 
In one case (cf.  Table II), the isolated myeloma protein was Gin(a-b+) when 
the normal "y-globulin of the same serum was Gm(a+b+).  The lack of the 
Gm(a) character in this myeloma protein is rather striking when one considers 
that in thirteen (65 per cent) of twenty cases the myeloma protein was Gm(a+) 
when the normal "y-globulin was Gm(a+). 
A  total of fifty-nine 7S  "y-, 19S  5%  and ~A-myeloma proteins  and Bence 
Jones proteins were tested for the Inv factors; thirty-four of them (58 per cent) 
were Inv(b+)  and five Inv(a+). If the presence of Inv(a) factor did not in- 
fluence the chance of having Inv(b)  in the same protein,  one would expect 
that three of the Inv(a+) proteins (58 per cent) be Inv(a+b+) and two Inv 
(a+b-),  whereas all were Inv(a+b-).  The findings on Bence Jones protein 
Ro. appear to be particularly significant. Of seven group I  Bence Jones pro- 
teins, all but one had an Inv character showing that there is a  very strong 
tendency to  express  the genetic information of the  individual to  the  Bence 
Jones protein if the latter is of type I. The type most frequently encountered 
was Inv(a-b+),  which is to be expected since about 80 per cent of all Ameri- 
cans are  of this type. The normal "y-globulin in serum Ro. was of type Inv 
(a+b+)  showing that she was a  heterozygote at this locus; the Bence Jones 
protein, however, contained only one of these characters being Inv(a+b-). 
These findings strongly suggest that in a  Gm(a+b+)  individual, the Gm(a) 
and Gin(b)  characters are present on different "),-globulin molecules and pro- 
duced by different cells. The same appears to be true for the Inv(a) and Inv(b) 
characters in an Inv(a+b+)  individual. If they were on the same molecule, 
or were produced by the same cells,  one would expect a  large percentage of 
myeloma proteins  to be  of  types Gm(a+b+)  and  Inv(a+b+).  It appears 
therefore that a  single clone of proliferating plasma cells has a  restricted ca- 
pacity to express its genetic information in its protein product: in the hetero- 
zygous individual only one of the genetic characters  of a  particular locus is 
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• Fig. 5 shows that a myeloma protein may be Gm(a+x+)  and Mtrtensson 
also found a myeloma protein of this type (32). This indicates that the Gin(a) 
and Gm(x) characters may be present on the same T-globulin molecules in a 
Gm(a+x+)  individual, or at least that they are both produced in the same 
cells. This might be expected since genetic evidence indicates that both Gin(a) 
and Gm(x) factors are the product of a single allele called Gm=, or in a slightly 
different interpretation by two genes, Gm ~ and Gm  X, which are closely linked 
and present on the same chromosome. 
The Gin(b) character was demonstrable in only two of forty-seven 7S T-mye- 
loma proteins. This low frequency is striking since the frequency of Gin(b+) 
individuals in the American white population is about 90 per cent (20).  The 
explanation of the rare occurrence of the Gin(b) character is of course of con- 
siderable  interest.  Two  main views may be  considered:  Firstly,  the  Gin(b) 
character may be present only on a small percentage of the T-globulin molecules 
in a normal Gm(b+) individual. If the malignant process arises as a result of 
proliferation of one clone of cells, one might then expect that the Gin(b) charac- 
ter be expressed in the myeloma protein in only a  small percentage of cases. 
Considerable indirect evidence appears  to support this view, and this is dis- 
cussed in detail in a  separate publication (45).  The evidence briefly is as fol- 
lows: The inhibiting capacity of Gin(b+)  myeloma proteins is  significantly 
greater  than that  of similarly isolated  Gm(b+)  7S  T-globulin from normal 
individuals (of.  Fig. 1 and reference 32).  Isolated antibodies may not possess 
all of the genetic characters which are present in the total 7S T-globulin of an 
individual; this is particularly striking for the Gin(b)  character which often 
appears  to be  absent in anti-Rh  7S  T-globulin of Gin(b+)  individuals  (17, 
46).  The allotypes of rabbit T-globulin (47) are very similar to the T-globulin 
types in humans. A certain allotypic specificity appears not to be present on all 
"y-globulin molecules in a given rabbit. The frequency of T-globnlin molecules 
carrying a  certain allotype specificity further varies for different specificities 
and is far from 100 per cent even in the homozygous state in some instances. 
The second possibility to explain the deficiency of the Gin(b) character is of 
course that the proteins are truly abnormal and deficient because of the malig- 
nant process.  This view appears considerably less likely; actually these studies 
have indicated an amazing similarity of the myeloma proteins and individual 
normal  T-globulins. 
A study of isolated 7S T-myeloma proteins from Negroes appeared promising 
as a means of stuying the character of the Gin(b)  type in Negroes. In whites, 
a Gm(a+b+) individual is heterozygous Gm"/C-m  b (17),  the genes controlling 
the two factors being on different chromosomes. In Negroes, the genetic situa- 
tion is markedly different in so far as all Negroes are  Gm(a+b+)  with the 
presumed genotype Gmab/Gm  "b. Here, both factors appear to be produced by a 
single allele on one chromosome (20). A highly surprising finding was the obser- :kf.  I-IARBOE,  C.  K.  OSTERLAND,  M.  M.ANN'IK,  l:i.  G.  KlYNKEL  735 
ration that all of six 7S "y-myeloma proteins from Negroes were Gm(a+b--). 
The low frequency of the Gm(b) factor in Negro myelomas indicate that the 
effect of gene Gmb is very similar indeed in the two races. Previously, the data 
on Negroes might be explained by the hypothesis that the  "Gm  substance" 
in Negroes was peculiar, having the ability to cross-react in both Gm(a) and 
Gm(b) test systems. Such a hypothesis is excluded by the present findings since 
it would imply that all myeloma proteins from Negroes be Gm(a+b+). 
SUMMARY 
The genetic factors  Gm(a),  Gm(b),  Gm(x),  and Inv(a), Inv(b) described 
for normal human ~,-globulin  were all found in different myeloma proteins. A 
single myeloma protein never contained more than one product of alternate 
alleles even in heterozygous individuals. However, factors determined by the 
two different loci were often found in the same myeloma protein. The Gm(a) 
character of the myeloma protein parallelled that of the normal ~,-globulin  of 
the same serum in most cases.  In contrast, the Gm(b) character was usual]y 
absent in the myeloma protein when it was directly demonstrable in the normal 
~,-globulin. The myeloma proteins from six Negroes were Gm(a+b--), whereas 
the normal "~,-globulin was Gm(a+b+). This indicates that the effect of gene 
C-m  b is similar in Negroes and whites, even though its relation to gene Gm  a is 
different in the two races. 
Gm factors were found only in the 7S "y-globulin type myelomas and not in 
other products of plasma cell  tumors. Inv characters were, however, present 
in all four types of proteins studied, namely 7S and 19S "y-globulins,/32A-glob- 
ulins, and Bence Jones proteins. In two instances, genetic heterogeneity of the 
protein products was demonstrated suggesting the proliferation of more than 
one clone of plasma cells in some multiple myeloma patients. 
The accumulated evidence obtained in this study strongly suggested that the 
presence and absence of genetic characters was compatible with the concept 
that myeloma proteins were  closely analogous to individual moieties in  the 
spectrum  of normal "v-globulins  rather  than truly abnormal proteins.  Their 
study offered evidence of a heterogeneity of genetic characters among the nor- 
mal "},-globulins in a given individual. It also appears probable that in normal 
individuals single plasma cells  have a  restricted capacity to express  genetic 
information in their protein product. 
We are grateful to Drs. 0. Hartmann, P. Herzog, C. Ropartz, and A. G. Steinberg for 
generous provision of reagents which made this work possible, and to Dr. P.  Schurr and 
numerous other physicians  for making  the myeloma  sera available  to us. 
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